CytoDyn Inc. announced a private placement of the units on January 13, 2023. Each unit will consist of one share of common stock and one warrant to purchase one share of common stock. The final purchase price per unit will be equal to 90% of the intraday volume weighted average price of the common stock or the intraday volume weighted average price of the common stock on the date of the final closing in the transaction, whichever is lower.

On the same date the company has received its first tranche.